e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Health & Science
Recent news which mentions Health & Science
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
32
33
Next >
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
January 08, 2025
Tags
Social issues
Biotechnology
Companies
From
CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
January 08, 2025
Tags
Bristol/Myers Squibb Co
Health care industry
Biotech and Pharmaceuticals
From
CNBC.com News
J&J says its lung cancer drug combination keeps people alive longer
January 07, 2025
Tags
Biotech and Pharmaceuticals
AstraZeneca PLC
Health & Science
From
CNBC.com News
Hims & Hers donates $1 million to Trump's inauguration fund
January 07, 2025
Tags
Breaking News: Politics
Meta Platforms Inc
Tesla Inc
From
CNBC.com News
U.S. surgeon general calls for cancer risk warnings on alcohol labels
January 03, 2025
Tags
Anheuser/Busch Inbev SA
Molson Coors Beverage Co
Health care industry
From
CNBC.com News
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
December 24, 2024
Tags
Dexcom Inc
US: News
Tempus AI Inc
From
CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
December 24, 2024
Tags
LILLY DRN
Business News
Weight management
From
CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
December 20, 2024
Tags
Biotechnology
Companies
Novo Nordisk A/S
From
CNBC.com News
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
December 19, 2024
Tags
Pharmaceuticals
Health & Science
US: News
From
CNBC.com News
Why Americans are outraged over health insurance — and what could change
December 18, 2024
Tags
Business News
UnitedHealth Group Inc
Health care industry
From
CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
December 18, 2024
Tags
Novo Nordisk A/S
Merck & Co Inc
Business News
From
CNBC.com News
Health AI startup Suki expands partnership with Google Cloud to deliver more assistive tech for clinicians
December 18, 2024
Tags
Technology
Health care industry
Alphabet Inc
From
CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
December 17, 2024
Tags
Social issues
Healthy Returns
Novo Nordisk A/S
From
CNBC.com News
Dexcom's over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levels
December 17, 2024
Tags
Technology
US: News
Dexcom Inc
From
CNBC.com News
UnitedHealth Group CEO addresses Brian Thompson death, says healthcare system is 'flawed'
December 13, 2024
Tags
Business News
UnitedHealth Group Inc
Companies
From
CNBC.com News
Health care stocks fall as lawmakers, patients push for changes to their business models
December 11, 2024
Tags
CVS Health Corp
Biotechnology
Companies
From
CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
December 11, 2024
Tags
Social issues
Healthy Returns
Roche Holding AG
From
CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
December 11, 2024
Tags
LILLY DRN
Novo Nordisk A/S
Business News
From
CNBC.com News
Insurance stocks have fallen since UnitedHealthcare CEO's killing
December 10, 2024
Tags
Health care industry
Cigna Corp
Biotech and Pharmaceuticals
From
CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
December 08, 2024
Tags
Novo Nordisk A/S
Cyber Report
Drugs
From
CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
December 05, 2024
Tags
Biotech and Pharmaceuticals
Health care industry
Bristol/Myers Squibb Co
From
CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
December 05, 2024
Tags
Biotechnology
Companies
Social issues
From
CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
December 04, 2024
Tags
Business News
LILLY DRN
Weight management
From
CNBC.com News
Mike Bloomberg warns making RFK Jr. HHS secretary risks killing Americans, urges Senate to reject him
December 03, 2024
Tags
US: News
White House
Health & Science
From
CNBC.com News
CDC says McDonald's E. coli outbreak is over
December 03, 2024
Tags
Business News
Companies
Environment
From
CNBC.com News
Healthy Returns: Trump’s FDA pick Makary may be a relief for biotech and pharma, analysts say
November 26, 2024
Tags
Biotech and Pharmaceuticals
Science
Health & Science
From
CNBC.com News
How President-elect Donald Trump may impact investors in these 8 market sectors
November 26, 2024
Tags
Health insurance
Retail
Meta Platforms Inc
From
CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
November 26, 2024
Tags
Amgen Inc
Novo Nordisk A/S
Breaking News: Business
From
CNBC.com News
Meet the start-up working to save newborn babies and democratize pregnancy care
November 26, 2024
Tags
Social issues
Business News
Health Care IT
From
CNBC.com News
Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
November 19, 2024
Tags
Novartis AG
Healthy Returns
Social issues
From
CNBC.com News
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.